Kainos Group plc Kainos Director/PDMR Shareholding (4460T)

TIDMKNOS

RNS Number : 4460T

Kainos Group plc

03 July 2018

03 July 2018

Kainos Group plc

("Kainos" or the "Company)

Director / PDMR shareholdings

The Company has been notified that on 02 July 2018, Paul Gannon, Director, sold 400,000 shares in the Company at an average price of 405p

Following this notification, Paul Gannon and his Connected Person have a reportable shareholding of 8,431,240 ordinary shares in the issued share capital of the Company, constituting 7.11% of the issued share capital of the Company.

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

 
 1.   Details of the person discharging managerial 
       responsibilities / person closely associated 
 a.   Name                            Paul Gannon 
     ------------------------------  --------------------------------- 
 2.   Reason for the notification 
     ----------------------------------------------------------------- 
 a.   Position/status                 Business Development Director 
     ------------------------------  --------------------------------- 
 b.   Initial notification            Initial 
       /Amendment 
     ------------------------------  --------------------------------- 
 3.   Details of the issuer, emission allowance 
       market participant, auction platform, auctioneer 
       or auction monitor 
     ----------------------------------------------------------------- 
 a.   Name                            Kainos Group plc 
     ------------------------------  --------------------------------- 
 b.   LEI                             213800H2PQMIF3OVZY47 
     ------------------------------  --------------------------------- 
 4.   Details of the transaction(s): section to 
       be repeated for (i) each type of instrument; 
       (ii) each type of transaction; (iii) each 
       date; and (iv) each place where transactions 
       have been conducted 
     ----------------------------------------------------------------- 
 a.   Description                     Ordinary Shares of GBP0.005 each 
       of the 
       Financial instrument/ 
       type of instrument              KNOS 
       Identification 
       code 
     ------------------------------  --------------------------------- 
 b.   Nature of the                   Disposal of Shares 
       transaction 
     ------------------------------  --------------------------------- 
 c.   Price(s) and                     Price(s)    Volume(s) 
       volume(s)                        GBP4.05     400,000 
                                                   ---------- 
     ------------------------------  --------------------------------- 
 d.        Aggregated 
            information                 N/A 
             *    Aggregated volume 
 
 
             *    Price 
     ------------------------------  --------------------------------- 
 e.   Date of the                     2017-07-02 
       transaction 
     ------------------------------  --------------------------------- 
 f.   Place of the                    LSE - Regulated Market - XLON 
       transaction 
     ------------------------------  --------------------------------- 
 

Ends

For further information, please contact:

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Investec Bank plc 44 20 7597 5970

Patrick Robb / Sebastian Lawrence

Canaccord Genuity [phone]

Simon Bridges / Emma Gabriel

FTI Consulting LLP [phone]

Matt Dixon / Harry Staight

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers; and Smart is an automated testing platform for Workday customers.

Kainos has over 1,150 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHEAEXDESDPEFF

(END) Dow Jones Newswires

July 03, 2018 06:54 ET (10:54 GMT)